Innovations in Clinical Care of CE Approved Nucleus Cochlear Implant Recipients

Launched by COCHLEAR · Feb 25, 2022

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Users of a CE approved Nucleus cochlear implant, resulting in open set speech understanding
• • At least three months of experience with the cochlear implant.
• • Older than 18 years when entering the study.
• • Subject is fluent speaker in the language used for assessments.
• • Open set speech understanding sufficient to complete the study protocol as judged by the investigator.
• • Willing and able to provide written informed consent
• Exclusion Criteria:
• • Unable or unwilling to comply with the requirements of the clinical investigation as determined by the investigator.
• • Additional health factors, known to the investigator, that would prevent or restrict participation in the audiological evaluations.
• • Investigator site personnel directly affiliated with this study and/or their immediate families; immediate family is defined as a spouse, parent, child, or sibling.
• • Cochlear employees or employees of Contract Research Organizations or contractors engaged by Cochlear for the purposes of this investigation.
• • Currently participating, or participated within the last 30 days, in another interventional clinical investigation/trial involving an investigational drug or device.